Skip to main content
FinSpry Logo
FinSpry
ELVN logo
ELVN
(NASDAQ)
Enliven Therapeutics, Inc.
$38.83-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Enliven Therapeutics (ELVN) Stock Price & Financial Analysis

Enliven Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$36.96 - $38.88
52-Week High$40.62
52-Week Low$13.30
Open$37.07
Volume810.85K
Average Volume (3M)810.85K
Market Cap2.20B
Shares Outstanding56.66M
Price to Book (P/B)4.66
EV/EBITDA-17.11
50-Day MA$29.23
200-Day MA$22.53
52-Week Change100.16%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Enliven Therapeutics

What is the current stock price for ELVN?

As of the latest trading session, ELVN stock trades at $38.83. The 52-week range is $13.30–$40.62, with a day range of $36.96–$38.88.

What is the P/E ratio for ELVN?

The P/E ratio (Price-to-Earnings) for ELVN is shown in the Key Statistics section. This valuation metric helps compare Enliven Therapeutics, Inc. to industry peers.

Does ELVN pay dividends?

Enliven Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ELVN?

Based on 4 analysts, the consensus for ELVN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ELVN?

Enliven Therapeutics's market capitalization is $2.20B, classifying it as a mid-cap company. Enliven Therapeutics operates in the Healthcare sector within the Biotechnology industry.